Toripalimab Combined With Anlotinib and SBRT in Patients With Untreated Brain Metastases of Driven Gene-negative NSCLC

Name: Toripalimab Combined With Anlotinib and SBRT in Patients With Untreated Brain Metastases of Driven Gene-negative NSCLC
Published: 2021
License: Public Domain

Hubei Cancer Hospital · 2021

ClinicalTrials.gov · Datasets · License: Public Domain · 2021

Open Source ↗

nsclc

nsclc, brain metastasis, toripalimab, anlotinib, sbrt, drive gene negative, interventional, phase1

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Toripalimab Combined With Anlotinib and SBRT in Patients With Untreated Brain Metastases of Driven Gene-negative NSCLC

Related documents